Cargando…
Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics
We describe the identification of a novel, tumor-specific missense mutation in the active site of casein kinase 1α (CSNK1A1) using activity-based proteomics. Matched normal and tumor colon samples were analyzed using an ATP acyl phosphate probe in a kinase-targeted LC-MS(2) platform. An anomaly in t...
Autores principales: | Okerberg, Eric S., Hainley, Anna, Brown, Heidi, Aban, Arwin, Alemayehu, Senait, Shih, Ann, Wu, Jane, Patricelli, Matthew P., Kozarich, John W., Nomanbhoy, Tyzoon, Rosenblum, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816389/ https://www.ncbi.nlm.nih.gov/pubmed/27031502 http://dx.doi.org/10.1371/journal.pone.0152934 |
Ejemplares similares
-
Correction: Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics
por: Okerberg, Eric S., et al.
Publicado: (2017) -
134. KRP-A218, an Orally Active and Selective PI4KB Inhibitor with Broad-Spectrum Anti-Rhinovirus Activity, Has Potent Therapeutic Antiviral Activity In vivo
por: Matsui, Toshiyuki, et al.
Publicado: (2021) -
PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells
por: Roy, Ajit, et al.
Publicado: (2023) -
Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2
por: Deng, Xianming, et al.
Publicado: (2011) -
Discovery of Type II Inhibitors of TGFβ-Activated
Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase
Kinase 2 (MAP4K2)
por: Tan, Li, et al.
Publicado: (2014)